Menu Search
Equities

Zentek Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ZAY0:DUS

Zentek Ltd

Actions
  • Price (EUR)0.535
  • Today's Change0.005 / 0.94%
  • Shares traded--
  • 1 Year change-49.05%
  • Beta0.4207
Data delayed at least 15 minutes, as of Feb 06 2026 18:32 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Zentek Ltd. is an intellectual property technology company. The Company is focused primarily on commercializing ZenGUARD, as well as on the development of certain aptamer technologies and other nanomaterials-based technologies. ZenGUARD is the Company’s patented anti-microbial coating technology platform. Its platform, ZenGUARD, has been shown to have enhanced bacterial and viral filtration efficiency for surgical masks and heating, ventilation, and air conditioning (HVAC) systems. The Company is also focused on the research, development and commercialization of novel products, seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener. The Company has installed industrial-scale production equipment to produce the ZenGUARD coating formulation. The Company is also working on developing processes to synthesize graphene, GO and graphene quantum dots, along with other possible applications for graphene-based materials.

  • Revenue in CAD (TTM)915.32k
  • Net income in CAD-8.19m
  • Incorporated2008
  • Employees17.00
  • Location
    Zentek Ltd24 Corporate CtGUELPH N1G 5G5CanadaCAN
  • Phone+1 (705) 618-0900
  • Fax+1 (705) 618-0900
  • Websitehttps://www.zentek.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.